Navigation Links
AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Date:9/3/2007

LOS ANGELES, Aug. 28 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) today announced that it is has named Homayoon Khanlou, M.D. as its Chief of Medicine, U.S. Prior to assuming his new role as Chief, Dr. Khanlou served as AHF's Associate Director of Medicine, Regional Medical Director of Western Region, while also holding the posts of AHF's Associate Director of Research and the Medical Director and attending physician for the San Fernando Valley and Antelope Valley Healthcare Centers. Dr. Khanlou has also served as Chair of the Pharmacy and Therapeutic Committee at AHF.

In addition to his extensive experience as a practicing HIV/AIDS physician, Dr. Khanlou is also a leading clinical researcher whose research has been published in such prestigious periodicals as the New England Journal of Medicine and the Archives of Internal Medicine. He is also a featured lecturer at a variety of medical institutions and has spoken the American Academy of Physicians Assistants, Children's Hospital of Los Angeles and a frequent speaker at the Los Angeles Intercity HIV Rounds.

"We are pleased to welcome Dr. Khanlou to the position of AIDS Healthcare Foundation's Chief of Medicine, U.S.," said Michael Weinstein, President of AIDS Healthcare Foundation. "In the eight years that Dr. Khanlou has been serving AHF patients, he has demonstrated noteworthy passion in providing the highest-quality medical care to his patients. To the position of Chief, Dr. Khanlou brings not only this dedication to excellence in patient care, but also his extensive experience as a top physician in the field and as a highly- regarded researcher and lecturer with deep knowledge of the latest in HIV/AIDS medicine. As our U.S. healthcare operations continue to expand, providing cutting-edge medical care to those in need, all of us at AHF look forward to working with Dr. Khanlou in this new leadership role."

Dr. Khanlou has practiced in a wide variety of medical communities in the U.S. and abroad including the Albert Einstein Medical Center in Philadelphia, Pennsylvania, Queen of Angels-Hollywood Presbyterian Medical Center, California Medical Center, Cedars-Sinai Medical Center, University of Los Angeles Medical Center, Cochin Hospital in Paris, France and Joffre Hospital in Draveil, France.

He completed his undergraduate work and received his medical degree from the Bobigny Medical School at the University of Paris XIII. He completed his residency in internal medicine and infectious diseases at University of Paris and postdoctoral training at the Laboratory of Pr. Didier Sicard at Cochin University Hospital. He also did another training at Albert Einstein Medical Center.

In addition to undertaking the duties of his new position, Dr. Khanlou will also serve as AHF's Medical Director of Research and will continue as the attending physician at the San Fernando Valley Healthcare Center. AHF's former Chief of Medicine, Charles F. Farthing, M.D., stepped down earlier this year in order to pursue opportunities in the private sector.

AIDS Healthcare Foundation (AHF) is the nation's largest non-profit HIV/AIDS healthcare, research, prevention and education provider, currently provides medical care and/or services to more than 61,000 individuals in 15 countries worldwide in the U.S., Africa, Latin America/Caribbean and Asia. http://www.aidshealth.org.


'/>"/>
SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
2. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
3. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
4. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Over 10,000 UK Breast Cancer Patients Could Become Eligible Within the Next Year for a Breast Cancer Therapy Showing Increased Survival Rates, Reveals Synovate Healthcare’s European Oncology Monitor
7. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
8. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
9. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
10. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
11. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):